AliveCor, maker of FDA-cleared, smartphone-based electrocardiogram devices, has named a new CEO, Vic Gundotra, former senior vice president at Google. Gundontra replaces board member Euan Thomson, who had been interim CEO since August 2013.
“Being able to understand what is going on inside heart disease through data analytics and machine learning has the potential to change the way we think of and participate in our healthcare,” Gundotra said in a company statement. “I am looking forward to being on the forefront of consumerizing medicine and working with an extremely intelligent team with innovative products.”
In his SVP role at Google, Gundotra ran the Google Plus social platform. He previously worked on mobile app development for the Internet search giant, and earlier in his career, was at Microsoft for 15 years, according to AliveCor.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Thomson took over as interim CEO from founder and CMO Dr. Dave Albert as AliveCor gained new investors and moved its headquarters from Oklahoma City to San Francisco. During his two-year tenure, the company won FDA clearances and CE marks for several new iterations of the original AliveECG product, including one compatible with Android phones.
Last month, AliveCor demonstrated a prototype ECG wristband for the Apple Watch. At the recent Connected Health Symposium in Boston, Albert showed MedCity News another prototype, a smartphone attachment that provides six leads of ECG data, not just the one on the FDA-cleared AliveECG product.